Get Premium

Get Premium

Dominate Financial Markets with Stock Target Advisor Premium Features

Discover
Discover

Explore new stock opportunities and market trends for better investment decisions.
- Analyst Ratings & Stock Picks
- Top Picks By AI
- Latest Analyst Ratings
- Analyst Directory
- Worst Stocks
- Sector Ratings & Performance
- Smart Filters
- Best Penny Stocks
- Best Dividend Stocks
- Best Crypto Stocks
- Best Performing Stocks
- Worst Performing Stocks
- Highest Income ETFs
Research
Research

Access in-depth stock analysis and expert evaluations to guide your investments
- Automatic Selection
- Stocks/ETF Screener
- Query Builder
- Analyst Screener
- Automated Research Reports
- Best Stocks Filters
- Thematic Stock Screens
- Sector Stock Screens
Learn
Learn

Utilize our extensive educational resources designed to enhance your investing knowledge and skills
- Market News & Insights
- Stock Target Advisor Insights
- Tutorials
- Market News
- Stock Calendars
- Earnings Calendar
- IPO Calendar
- Splits Calendar
Watchlists & Portfolios
Watchlists & Portfolios

Easily manage, track, and optimize your stock selections for maximum returns
Engage
Engage

Connect with the investing community and access free widgets for better stock insights
Pricing

Guessing Isn’t a Strategy!

Use Research That Shows You What to Buy, When to Buy, and Why—Now Upto 70% OFF! Claim Now

Xeris Pharmaceuticals Inc (XERS) Stock Analyst Ratings & Price Targets

COMMON STOCK | Biotechnology | NSD

Target Add to Watchlist

Take a Tour

Buy

Average Analyst
Rating

Slightly Bullish

Stock Target Advisor
Analysis

Strong Buy

Average User
Rating

Last Closing Price

USD 4.28

Change

+0.15 (+3.63%)

Market Cap

USD 0.64B

Volume

1.69M

Avg User Target

USD 3.25 (-24.07%)

XERS

Xeris Pharmaceuticals Inc (USD)

COMMON STOCK | NSD

USD 4.28

+0.15 ( +3.63%)

Watchlist

Xeris Pharmaceuticals Inc (XERS) Stock Forecast

Show ratings and price targets of :

All Analysts

Top Analysts

Average Analyst Target

USD 5.40

(+26.17%)

Based on the Xeris Pharmaceuticals Inc stock forecast from 2 analysts, the average analyst target price for Xeris Pharmaceuticals Inc is USD 5.40 over the next 12 months. Xeris Pharmaceuticals Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Xeris Pharmaceuticals Inc is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, Xeris Pharmaceuticals Inc’s stock price was USD 4.28. Xeris Pharmaceuticals Inc’s stock price has changed by +4.14% over the past week, -27.09% over the past month and +151.76% over the last year.

Analyst Ratings

Filter:

Show:

Target Price Action	Rating Action	Analyst	Rating	Price	Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.